Publication: Paragraph 6 of the Doha Declaration on the TRIPS Agreement and Public Health: Options for TRIPS Council
| dash.license | LAA | |
| dc.contributor.author | Attaran, Amir | |
| dc.date.accessioned | 2020-02-10T10:51:07Z | |
| dc.date.available | 2020-02-10T10:51:07Z | |
| dc.date.issued | 2002-03 | |
| dc.description.abstract | This Working Paper is organized in the following parts. We first analyze Paragraph 6 and the Doha Declaration in detail, to appreciate accurately the mandate created by the WTO Ministerial. We then consider two current proposals from the NGO community and the European Commission, and discuss these in relation to the Paragraph 6 mandate. We then offer a proposal of our own, which we believe excels in resolving the Paragraph 6 mandate and the problem of pharmaceuticals access more generally. Finally, we discuss some legal issues not in the TRIPS, but in the GATT, which affect the subject matter of the Doha Declaration. | en_US |
| dc.description.version | Accepted Manuscript | en_US |
| dc.identifier.citation | Attaran, Amir. “Paragraph 6 of the Doha Declaration on the TRIPS Agreement and Public Health: Options for TRIPS Council.” CID Working Paper Series 2002.87, Harvard University, Cambridge, MA, March 2002. | en_US |
| dc.identifier.uri | http://nrs.harvard.edu/urn-3:HUL.InstRepos:42402004 | * |
| dc.language.iso | en_US | en_US |
| dc.publisher | Center for International Development at Harvard University | en_US |
| dc.relation.isversionof | https://www.hks.harvard.edu/centers/cid/publications | en_US |
| dc.relation.journal | CID Working Paper Series | en_US |
| dc.title | Paragraph 6 of the Doha Declaration on the TRIPS Agreement and Public Health: Options for TRIPS Council | en_US |
| dc.type | Research Paper or Report | en_US |
| dspace.entity.type | Publication | |
| oaire.licenseCondition | LAA |